|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Peripheral arterial disease, type 2 diabetes and postprandial lipidaemia: Is there a link?显示文摘Peripheral arterial disease, manifested as intermittent claudication or critical ischaemia, or identified by an ankle/brachial index < 0.9, is present in at least one in every four patients with type 2 diabetes mellitus.Several reasons exist for peripheral arterial disease indiabetes. In addition to hyperglycaemia, smoking and hypertension, the dyslipidaemia that accompanies type2 diabetes and is characterised by increased triglyceride levels and reduced high-density lipoprotein cholesterol concentrations also seems to contribute to this association. Recent years have witnessed an increased interest in postprandial lipidaemia, as a result of various prospective studies showing that non-fasting triglycerides predict the onset of arteriosclerotic cardiovascular disease better than fasting measurements do. Additionally,the use of certain specific postprandial particle markers,such as apolipoprotein B-48, makes it easier and more simple to approach the postprandial phenomenon. Despite this, only a few studies have evaluated the role of postprandial triglycerides in the development of peripheral arterial disease and type 2 diabetes. The purpose of this review is to examine the epidemiology and risk factors of peripheral arterial disease in type 2 diabetes, focusing on the role of postprandial triglycerides and particles. | Pedro Valdivielso José Ramírez-Bollero Carmen Pérez-López | 2014 | World Journal of Diabetes2014，5，5： | 2 |
| 2 | Effect of apoiipoprotein C3 and apolipoprotein A1 polymorphisms on postprandial response to a fat overload in met- abolic syndrome patients 显示文摘 | Clemente - Postigo M Queipo - Ortuo M Valdivielso P | 2010 | Clin Biochem2010，43，1617： | 1 |
| 3 | Smoking and postprandial triglycerides are associated with vascular disease in patients with type 2 diabetes 显示文摘 | VALDIVIELSO P HIDALGO A RIOJA J | 2007 | Atherosclerosis2007，194，： | 1 |
| 4 | Effects of interferon-beta on plasma lipid and lipoprotein composition and post-heparin lipase activities in patients with chronic hepatitis C显示文摘 | Andrade RJ Garcia-Escano MD Valdivielso P | 2000 | Aliment Pharmacol Ther2000，14，7： | 1 |
| 5 | Current knowledge ofhypertriglyceridemic pancreatitis显示文摘 | Valdivielso P Ramirez-Bueno A Ewald N | 2014 | Eur J Intern Med2014，25，8： | 1 |
| 6 | Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic panereatitis显示文摘 | Coea-Prieto I Valdivielso P Olivecrona G | 2009 | BMC Gastroenterol2009，9，： | 1 |
| 7 | Effect of apolipoprotein C3 and apolipoprotein A1 polymorphisms on postprandial response to a fat overload in metabolic syndrome patients显示文摘 | Clemente-Postigo M Queipo-Ortuno M Valdivielso P | 2010 | Clin Biochem2010，43，： | 1 |
| 8 | Association of moderate and severe hypertriglyceridemia with obesity,diabetes mellitus and vascular disease in the Spanish working population: results of the ICARIA study显示文摘 | Valdivielso P Sanchez-Chaparro MA Calvo-Bonacho E | 2009 | Ather- oselerosis2009，207，2： | 1 |
| 9 | ApoB48 as a marker of athrosclerosis in patients with familial lipid disorders type 2 diabetes mellitus and coronary artery disease显示文摘 | Alipour A Valdivielso P Elte JWF | | 0，，01： | 1 |
| 10 | Atorvastatin in dyslip idaemia of the nephrotic syndrome显示文摘 | Valdivielso P Moliz M Valera A | 2003 | Nephrology(Carlton)2003，，2： | 1 |
| 11 | Atorvastatin in dyslipidaemia of the nephrotic syndrome显示文摘 | Valdivielso P Moliz M Valera A | 2003 | Nephrology(Carlton)2003，8，2： | 1 |
| 12 | Atorvastatin in dysiip idae ma of the nephrotic syndrome显示文摘 | Valdivielso P Moliz M Valera A | 2003 | Nephrology(Carlton)2003，，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员